Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Maceron Nov 29, 2019 3:56pm
137 Views
Post# 30406938

RE:RE:RE:It would be a good idea to load today

RE:RE:RE:It would be a good idea to load today
Eoganacht wrote: I don't think it's fair to accuse Theralase of going too slow. They are a small company with limited resources who may be bringing a safe, effective and innovative treatment for cancer to market within the next 2 years with almost no outside help.

As Drs. Lilge and McFarland wrote in their Oct 2018 article:

"TLD1433 progressed from the bench to a clinical trial in 6 years thanks to efforts of a highly productive and motivated multidisciplinary team of chemists, biologists, medical biophysicists, engineers, clinicians, investors, industrial partners, and lawyers. The early identification of the target indication, NMIBC, facilitated the parallel development of compound, medical device, and PDT package via a tumor-centered approach. The creation of a photosensitizer is only one moving part in a much larger machine, and researchers making these compounds must not lose sight of the big picture."

I'm just happy I was lucky enough to be able to go along for the ride.


Bunge wrote:
DukeDilligence wrote: ...

Yes.

We know TLT.

The faster the better.
 




Agreed. The pace is appropriate, Even though bladder cancer may be quite prominent, the criteria that make patients eligable for the study is like trying to find a four leaf clover. The fact that they have treated 4 at PMH inside of 4-5 months is fantastic. McGill is now treating and look for London to right there too.
I would hazard a guess that we will see at least one more Canadian site prior to xmas and FDA announced Jan 1. Either way I think it is safe to assume that no news no longer means nothing is happening behind the scenes. Makes for pleasant update, but laser is going to go bannanas without concrete dates to work with....just teasing laser!
Macer
Bullboard Posts